These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 1465810

  • 21. Cold ischemia time and MHC class II matching in renal transplants.
    Iwaki Y, Cicciarelli J, Aswad S, Gavazov M, Obispo E, Khetan U, Bogaard T, Asai P, Mendez RG, Mendez R.
    Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
    [No Abstract] [Full Text] [Related]

  • 22. DR6 compatibility and kidney graft survival.
    Correia AM, de Costa AG, Reis P, Rego F, Sampaio MJ, Caetano JM, Pena JR.
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract] [Full Text] [Related]

  • 23. Is superior graft survival of multiorgan donor kidneys due to better preservation or better organ selection?
    Albrecht KH, Rudy T, Niebel W, Eigler FW.
    Transplant Proc; 1992 Dec; 24(6):2748-9. PubMed ID: 1465925
    [No Abstract] [Full Text] [Related]

  • 24. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
    Park K, Kim YS, Kim SI.
    Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
    [No Abstract] [Full Text] [Related]

  • 25. HLA matching in liver transplantation: a retrospective analysis.
    Gunson BK, Hathaway M, Buckels JA, Mayer AD, Elias E, McMaster P, Neuberger JM.
    Transplant Proc; 1992 Dec; 24(6):2434-5. PubMed ID: 1465819
    [No Abstract] [Full Text] [Related]

  • 26. Kidney transplantation in Slovenia from 1986 through 1991.
    Kandus A, Buturović-Ponikvar J, Malovrh M, Bren AF.
    Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
    [No Abstract] [Full Text] [Related]

  • 27. HLA typing on peripheral blood lymphocytes from cadaveric donors to reduce cold ischemia.
    Muñoz C, Franco A, Prados MC, de la Sen ML, Perdiguero M, Olivares J.
    Transplant Proc; 1992 Dec; 24(6):2490-1. PubMed ID: 1465840
    [No Abstract] [Full Text] [Related]

  • 28. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
    Velidedeoğlu E, Tokyay R, Haberal M.
    Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
    [No Abstract] [Full Text] [Related]

  • 29. HLA-DR matching defined by SSO-typing in heart transplantation.
    Poli F, Scalamogna M, Pappalettera M, Mascaretti L, Nocco A, Crespiatico L, Sirchia G.
    Transplant Proc; 1992 Dec; 24(6):2436-7. PubMed ID: 1465820
    [No Abstract] [Full Text] [Related]

  • 30. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
    Schweizer RT, Roper L, Hull D, Bartus SA.
    Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
    [No Abstract] [Full Text] [Related]

  • 31. HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
    Adam K, Polymenidis Z, Papakyriazi L, Alexopoulos E, Parapanissiou E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2449-50. PubMed ID: 1465825
    [No Abstract] [Full Text] [Related]

  • 32. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
    Mourad G, Cristol JP, Chong G, Lorho R, Argiles A, Seignalet J, Mion C.
    Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
    [No Abstract] [Full Text] [Related]

  • 33. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M, Piazza A, Torlone N, Poggi E, Monaco PI, Provenzani L, Adorno D, Casciani CU.
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract] [Full Text] [Related]

  • 34. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
    Christiaans MH, van den Berg-Loonen PM, Nieman FH, van Hooff JP.
    Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
    [No Abstract] [Full Text] [Related]

  • 35. Molecular matching in renal transplantation.
    Bein G, Gläser R, Eiermann TH, Hoyer J, Haase D, Kirchner H.
    Transplant Proc; 1992 Dec; 24(6):2475-7. PubMed ID: 1465838
    [No Abstract] [Full Text] [Related]

  • 36. Current experience with renal transplantation across the ABO blood group barrier.
    Bryan CF, Nelson PW, Aeder MI, Beck ML, Helling TS, Hughes TM, Luger AM, Pierce GE, Shield CF.
    Transplant Proc; 1992 Dec; 24(6):2527-9. PubMed ID: 1465854
    [No Abstract] [Full Text] [Related]

  • 37. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM, Sánchez J, Sánchez P, García J, Orero E, Beneyto I, Ros F.
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract] [Full Text] [Related]

  • 38. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
    Middleton D, Martin J, Magee BA, Douglas JF.
    Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
    [No Abstract] [Full Text] [Related]

  • 39. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E, Bittar AE, Losekann A, Deboni L, Ceretta F, Goldani JC, Garcia VD.
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract] [Full Text] [Related]

  • 40. Effect of recipient gender and race on heart and kidney allograft survival.
    Reed E, Cohen DJ, Barr ML, Ho E, Reemtsma K, Rose EA, Hardy M, Suciu-Foca N.
    Transplant Proc; 1992 Dec; 24(6):2670-1. PubMed ID: 1465895
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.